Press "Enter" to skip to content

New patent expiration for Ucb Inc drug NEUPRO

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Ucb Inc drug NEUPRO

Annual Drug Patent Expirations for NEUPRO
Annual Drug Patent Expirations for NEUPRO

Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge.

NEUPRO drug price trends.

Drug patent litigation for NEUPRO.

This drug has one hundred and forty-three patent family members in thirty-eight countries.

The generic ingredient in NEUPRO is rotigotine. One supplier is listed for this compound. Additional details are available on the rotigotine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Ucb Inc drug NEUPRO

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!